Skip to main content
. 2022 Mar 18;11(7):e022852. doi: 10.1161/JAHA.121.022852

Table 10.

Association Between Plasma Ceramides and CFR

Adjusted model Standardized β coefficient P value
1
Age −0.01 0.170
Sex −0.20 0.116
Plasma ceramides 18:0/24:0 −9.78 0.034
2
Age −0.01 0.169
Sex −0.22 0.108
Hypertension 0.09 0.426
Diabetes −0.06 0.718
Hyperlipidemia −0.04 0.757
Lipid‐lowering drug use 0.02 0.869
Plasma ceramides 18:0/24:0 −9.88 0.040
3
Age −0.01 0.114
Sex −0.19 0.180
Hypertension 0.06 0.599
Diabetes −0.01 0.964
Hyperlipidemia −0.02 0.873
Lipid‐lowering drug use −0.01 0.961
LDL cholesterol −0.01 0.115
Non‐HDL cholesterol 0.01 0.097
Plasma ceramides 18:0/24:0 −12.80 0.016
1
Age −0.01 0.123
Sex −0.19 0.148
Plasma ceramides 16:0/24:0 −5.35 0.014
2
Age −0.01 0.162
Sex −0.22 0.115
Hypertension 0.07 0.560
Diabetes −0.06 0.741
Hyperlipidemia −0.07 0.637
Lipid‐lowering drug use −0.03 0.803
Plasma ceramides 16:0/24:0 0.016
3
Age −0.01 0.091
Sex −0.19 0.185
Hypertension 0.03 0.783
Diabetes −0.02 0.941
Hyperlipidemia −0.05 0.735
Lipid‐lowering drug use −0.05 0.761
LDL cholesterol −0.00 0.454
Non‐HDL cholesterol −0.00 0.405
Plasma ceramides 16:0/24:0 −5.57 0.015
1
Age −0.01 0.154
Sex −0.20 0.117
Plasma ceramides 24:1/24:0 −1.38 0.044
2
Age −0.01 0.175
Sex −0.23 0.094
Hypertension 0.10 0.409
Diabetes −0.06 0.727
Hyperlipidemia −0.06 0.671
Lipid‐lowering drug use −0.02 0.878
Plasma ceramides 24:1/24:0 −1.42 0.044
3
Age −0.01 0.113
Sex −0.20 0.164
Hypertension 0.06 0.613
Diabetes −0.02 0.908
Hyperlipidemia −0.02 0.888
Lipid‐lowering drug use −0.08 0.601
LDL cholesterol −0.01 0.140
Non‐HDL cholesterol 0.01 0.146
Plasma ceramides 24:1/24:0 −1.74 0.022

Linear regression models consecutively adjusted for cardiovascular risk factors and lipids. HDL indicates high‐density lipoprotein; and LDL, low‐density lipoprotein.